S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
NYSEARCA:IBRN

iShares Neuroscience and Healthcare ETF (IBRN) Price, Holdings, & News

$26.35
+0.60 (+2.33%)
(As of 03/1/2024 ET)
Today's Range
$25.85
$26.35
50-Day Range
$25.32
$26.77
52-Week Range
$19.08
$26.90
Volume
2,859 shs
Average Volume
951 shs
Market Capitalization
$5.27 million
Assets Under Management
$3.95 million
Dividend Yield
0.03%
Net Expense Ratio
0.47%

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.

IBRN Stock Price History

IBRN ETF News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive IBRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
iShares
Fund Name
iShares Neuroscience and Healthcare ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:IBRN
Inception Date
8/24/2022
Fund Manager
Jennifer Hsui, Greg Savage, Paul Whitehead, Amy Whitelaw
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE FactSet Global Neuro Biopharma and MedTech Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
51

Fund Statistics

Assets Under Management
$3.86 million
Average Daily Volume
$0.00
Discount/Premium
0.03%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Flow Traders

Miscellaneous

Beta
1.36
Creation Unit
50,000
Creation Fee
$350.00
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

iShares Neuroscience and Healthcare ETF Expenses

TypeIBRNTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.47%0.57%0.54%0.50%0.51%
Other Expenses0.00%0.72%0.55%0.64%0.58%
Total Expense0.47%0.72%0.70%0.74%0.70%
Fee Waiver0.00%-0.77%-0.55%-0.69%-0.57%
Net Expense0.47%0.59%0.60%0.57%0.58%

iShares Neuroscience and Healthcare ETF (IBRN) Holdings & Exposure

IBRN Sector Exposure

IBRN Industry Exposure















IBRN ETF - Frequently Asked Questions

How have IBRN shares performed in 2024?

iShares Neuroscience and Healthcare ETF's stock was trading at $26.23 on January 1st, 2024. Since then, IBRN shares have increased by 0.4% and is now trading at $26.3473.
View the best growth stocks for 2024 here
.

What does IBRN invest in?

iShares Neuroscience and Healthcare ETF is a equity fund issued by iShares. IBRN focuses on theme investments and follows the NYSE FactSet Global Neuro Biopharma and MedTech Index. The fund's investments total to approximately $3.95 million assets under management.

What is the management fee for iShares Neuroscience and Healthcare ETF?

iShares Neuroscience and Healthcare ETF's management fee is 0.47% and has no other recorded expenses or fee waivers. The net expense ratio for IBRN is 0.47%.

How do I buy shares of iShares Neuroscience and Healthcare ETF?

Shares of IBRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:IBRN) was last updated on 3/2/2024 by MarketBeat.com Staff